Claudia Un-Yong Chae, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Perimenopause | 3 | 2011 | 142 | 0.650 |
Why?
|
| Postmenopause | 6 | 2019 | 2514 | 0.370 |
Why?
|
| Heart Failure | 15 | 2019 | 11701 | 0.350 |
Why?
|
| Vitamin E | 2 | 2012 | 872 | 0.310 |
Why?
|
| Women's Health | 5 | 2022 | 2070 | 0.300 |
Why?
|
| Blood Pressure | 9 | 2016 | 8479 | 0.260 |
Why?
|
| Primary Prevention | 2 | 2012 | 1185 | 0.260 |
Why?
|
| Antioxidants | 2 | 2012 | 1667 | 0.250 |
Why?
|
| Premenopause | 3 | 2008 | 1039 | 0.240 |
Why?
|
| Hematocrit | 1 | 2005 | 623 | 0.230 |
Why?
|
| Coronary Disease | 13 | 2009 | 5921 | 0.210 |
Why?
|
| Dyspnea | 7 | 2012 | 1347 | 0.210 |
Why?
|
| Chest Pain | 6 | 2012 | 1097 | 0.210 |
Why?
|
| Estrogen Replacement Therapy | 2 | 2001 | 1208 | 0.200 |
Why?
|
| Cardiovascular Diseases | 10 | 2020 | 15521 | 0.200 |
Why?
|
| Renal Insufficiency | 2 | 2005 | 808 | 0.190 |
Why?
|
| Anti-Mullerian Hormone | 1 | 2022 | 407 | 0.170 |
Why?
|
| Dietary Supplements | 2 | 2012 | 3410 | 0.160 |
Why?
|
| Lipoproteins | 2 | 2022 | 877 | 0.160 |
Why?
|
| Death, Sudden, Cardiac | 5 | 2006 | 1560 | 0.160 |
Why?
|
| Ventricular Dysfunction, Left | 2 | 2010 | 2131 | 0.160 |
Why?
|
| Natriuretic Peptide, Brain | 5 | 2007 | 1725 | 0.150 |
Why?
|
| Peptide Fragments | 5 | 2007 | 5103 | 0.130 |
Why?
|
| Anemia | 1 | 2005 | 1504 | 0.130 |
Why?
|
| Hormone Replacement Therapy | 2 | 2019 | 751 | 0.120 |
Why?
|
| Risk Factors | 28 | 2020 | 74241 | 0.120 |
Why?
|
| Hypertension | 7 | 2017 | 8536 | 0.120 |
Why?
|
| Menopause | 3 | 2022 | 1646 | 0.110 |
Why?
|
| Troponin I | 3 | 2005 | 652 | 0.110 |
Why?
|
| Hot Flashes | 1 | 2016 | 330 | 0.110 |
Why?
|
| Lipids | 3 | 2005 | 3331 | 0.110 |
Why?
|
| Triage | 3 | 2010 | 985 | 0.100 |
Why?
|
| Blood Pressure Determination | 1 | 2016 | 633 | 0.100 |
Why?
|
| Carotid Artery Diseases | 1 | 2018 | 877 | 0.100 |
Why?
|
| Risk Assessment | 5 | 2020 | 24022 | 0.100 |
Why?
|
| Middle Aged | 41 | 2022 | 220858 | 0.090 |
Why?
|
| Myocardial Infarction | 9 | 2012 | 11476 | 0.090 |
Why?
|
| Physical Exertion | 2 | 2006 | 668 | 0.090 |
Why?
|
| Population Surveillance | 1 | 2020 | 2598 | 0.080 |
Why?
|
| Coronary Angiography | 4 | 2012 | 4507 | 0.080 |
Why?
|
| Atrial Fibrillation | 3 | 2017 | 5114 | 0.080 |
Why?
|
| Female | 44 | 2022 | 392552 | 0.080 |
Why?
|
| Prospective Studies | 22 | 2018 | 54437 | 0.080 |
Why?
|
| Flavones | 1 | 2007 | 68 | 0.070 |
Why?
|
| Acute Disease | 9 | 2010 | 7226 | 0.070 |
Why?
|
| Coronary Stenosis | 3 | 2010 | 802 | 0.070 |
Why?
|
| United States | 17 | 2020 | 72341 | 0.070 |
Why?
|
| Flavonols | 1 | 2007 | 85 | 0.070 |
Why?
|
| Triglycerides | 3 | 2022 | 2457 | 0.070 |
Why?
|
| Acute Coronary Syndrome | 2 | 2010 | 2194 | 0.070 |
Why?
|
| Angina, Unstable | 3 | 2006 | 890 | 0.070 |
Why?
|
| Tyrosine | 2 | 2001 | 1422 | 0.070 |
Why?
|
| Aged | 27 | 2019 | 169292 | 0.070 |
Why?
|
| Aging | 2 | 2009 | 8702 | 0.060 |
Why?
|
| Aging, Premature | 1 | 2005 | 44 | 0.060 |
Why?
|
| Myoglobin | 1 | 2005 | 159 | 0.060 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2020 | 3245 | 0.060 |
Why?
|
| Linear Models | 4 | 2009 | 5869 | 0.060 |
Why?
|
| Incidence | 5 | 2017 | 21366 | 0.060 |
Why?
|
| Waist Circumference | 1 | 2009 | 933 | 0.060 |
Why?
|
| Humans | 50 | 2022 | 761222 | 0.060 |
Why?
|
| alpha-Linolenic Acid | 1 | 2005 | 144 | 0.060 |
Why?
|
| Cholesterol | 2 | 2011 | 2902 | 0.060 |
Why?
|
| Creatine Kinase, MB Form | 1 | 2005 | 202 | 0.060 |
Why?
|
| Streptococcus anginosus | 1 | 2004 | 24 | 0.060 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2010 | 20588 | 0.060 |
Why?
|
| Angina Pectoris | 2 | 2005 | 959 | 0.060 |
Why?
|
| Diabetes Complications | 3 | 2017 | 1316 | 0.060 |
Why?
|
| Lamin Type A | 1 | 2005 | 187 | 0.060 |
Why?
|
| Follow-Up Studies | 7 | 2019 | 39127 | 0.060 |
Why?
|
| Creatinine | 3 | 2005 | 1897 | 0.060 |
Why?
|
| Double-Blind Method | 3 | 2019 | 12341 | 0.060 |
Why?
|
| Cause of Death | 3 | 2011 | 3688 | 0.050 |
Why?
|
| Body Height | 1 | 2009 | 1566 | 0.050 |
Why?
|
| Coronary Artery Disease | 4 | 2012 | 6506 | 0.050 |
Why?
|
| Cohort Studies | 10 | 2017 | 41496 | 0.050 |
Why?
|
| Sex Hormone-Binding Globulin | 1 | 2005 | 550 | 0.050 |
Why?
|
| Phobic Disorders | 1 | 2005 | 439 | 0.050 |
Why?
|
| Acetaminophen | 1 | 2006 | 555 | 0.050 |
Why?
|
| Body Mass Index | 6 | 2017 | 12952 | 0.050 |
Why?
|
| Inflammation | 1 | 2001 | 10759 | 0.050 |
Why?
|
| Blood Glucose | 3 | 2011 | 6392 | 0.050 |
Why?
|
| Insulin | 3 | 2011 | 6588 | 0.050 |
Why?
|
| Health Surveys | 1 | 2011 | 4037 | 0.050 |
Why?
|
| Risk | 7 | 2011 | 9616 | 0.050 |
Why?
|
| Apolipoprotein A-I | 1 | 2022 | 299 | 0.050 |
Why?
|
| Exercise | 3 | 2018 | 5874 | 0.050 |
Why?
|
| Multivariate Analysis | 5 | 2007 | 12052 | 0.050 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 2 | 2001 | 578 | 0.050 |
Why?
|
| Apolipoproteins B | 1 | 2022 | 385 | 0.050 |
Why?
|
| Myocardial Revascularization | 1 | 2005 | 794 | 0.050 |
Why?
|
| Time Factors | 5 | 2012 | 39957 | 0.050 |
Why?
|
| Abscess | 1 | 2004 | 605 | 0.050 |
Why?
|
| Oxidative Stress | 1 | 2012 | 3114 | 0.050 |
Why?
|
| Male | 27 | 2011 | 360703 | 0.040 |
Why?
|
| Prothrombin | 1 | 2001 | 192 | 0.040 |
Why?
|
| Endocarditis, Bacterial | 1 | 2004 | 436 | 0.040 |
Why?
|
| Selective Estrogen Receptor Modulators | 1 | 2001 | 131 | 0.040 |
Why?
|
| Adult | 23 | 2022 | 221120 | 0.040 |
Why?
|
| Streptococcal Infections | 1 | 2004 | 617 | 0.040 |
Why?
|
| C-Reactive Protein | 2 | 2009 | 3821 | 0.040 |
Why?
|
| Sensitivity and Specificity | 7 | 2010 | 14675 | 0.040 |
Why?
|
| Hemostasis | 2 | 2005 | 470 | 0.040 |
Why?
|
| Systole | 3 | 2010 | 936 | 0.040 |
Why?
|
| Hospitalization | 1 | 2019 | 10707 | 0.040 |
Why?
|
| Medical Records | 1 | 2005 | 1409 | 0.040 |
Why?
|
| Fibrinolysis | 1 | 2001 | 332 | 0.040 |
Why?
|
| Longitudinal Studies | 4 | 2016 | 14610 | 0.040 |
Why?
|
| Estradiol | 2 | 2022 | 1937 | 0.040 |
Why?
|
| Medroxyprogesterone Acetate | 1 | 2019 | 155 | 0.040 |
Why?
|
| Endothelium | 1 | 2001 | 763 | 0.040 |
Why?
|
| Estrogens, Conjugated (USP) | 1 | 2019 | 276 | 0.040 |
Why?
|
| beta Carotene | 1 | 1999 | 523 | 0.040 |
Why?
|
| Receptors, Cell Surface | 1 | 2007 | 2802 | 0.040 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2001 | 1128 | 0.040 |
Why?
|
| Androgens | 1 | 2005 | 1283 | 0.040 |
Why?
|
| Proportional Hazards Models | 5 | 2009 | 12474 | 0.040 |
Why?
|
| Epidemiologic Studies | 1 | 2001 | 677 | 0.040 |
Why?
|
| Predictive Value of Tests | 6 | 2010 | 15308 | 0.030 |
Why?
|
| Heart Valve Diseases | 1 | 2004 | 1031 | 0.030 |
Why?
|
| Aged, 80 and over | 11 | 2007 | 58952 | 0.030 |
Why?
|
| Emergency Service, Hospital | 5 | 2009 | 7865 | 0.030 |
Why?
|
| Heparin | 2 | 2001 | 1632 | 0.030 |
Why?
|
| Cholesterol, HDL | 1 | 2022 | 1812 | 0.030 |
Why?
|
| Smoking | 4 | 2018 | 9055 | 0.030 |
Why?
|
| Lipoprotein(a) | 1 | 2001 | 482 | 0.030 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2006 | 2270 | 0.030 |
Why?
|
| Emergency Medicine | 1 | 2005 | 1198 | 0.030 |
Why?
|
| Antihypertensive Agents | 1 | 2005 | 2019 | 0.030 |
Why?
|
| Vasomotor System | 1 | 2016 | 208 | 0.030 |
Why?
|
| Asymptomatic Diseases | 1 | 2018 | 588 | 0.030 |
Why?
|
| Survival Rate | 3 | 2007 | 12728 | 0.030 |
Why?
|
| Atherosclerosis | 1 | 2011 | 3407 | 0.030 |
Why?
|
| Alopecia | 1 | 2000 | 412 | 0.030 |
Why?
|
| Diet | 2 | 2018 | 8048 | 0.030 |
Why?
|
| Morbidity | 1 | 2020 | 1751 | 0.030 |
Why?
|
| ROC Curve | 3 | 2009 | 3584 | 0.030 |
Why?
|
| Platelet Aggregation Inhibitors | 2 | 2011 | 2746 | 0.030 |
Why?
|
| Cross-Sectional Studies | 3 | 2008 | 26072 | 0.030 |
Why?
|
| Syndrome | 3 | 2006 | 3271 | 0.030 |
Why?
|
| Hypotension | 1 | 2000 | 879 | 0.030 |
Why?
|
| Aortic Valve | 1 | 2004 | 1959 | 0.030 |
Why?
|
| Community-Based Participatory Research | 1 | 2016 | 221 | 0.030 |
Why?
|
| Single-Blind Method | 2 | 2009 | 1577 | 0.030 |
Why?
|
| Diagnosis, Differential | 4 | 2012 | 12976 | 0.030 |
Why?
|
| Diastole | 2 | 2010 | 782 | 0.030 |
Why?
|
| Cholesterol, LDL | 1 | 2022 | 2380 | 0.030 |
Why?
|
| Vasodilator Agents | 1 | 1997 | 989 | 0.030 |
Why?
|
| Myocardial Ischemia | 2 | 2001 | 2133 | 0.030 |
Why?
|
| Nerve Tissue Proteins | 1 | 2005 | 4404 | 0.020 |
Why?
|
| Obesity | 3 | 2017 | 12940 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2001 | 3210 | 0.020 |
Why?
|
| Fibrinolytic Agents | 1 | 2000 | 2075 | 0.020 |
Why?
|
| Retrospective Studies | 3 | 2012 | 80675 | 0.020 |
Why?
|
| Age Factors | 2 | 2006 | 18384 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 1999 | 6223 | 0.020 |
Why?
|
| Stroke Volume | 2 | 2019 | 5521 | 0.020 |
Why?
|
| Factor VII | 1 | 2009 | 139 | 0.020 |
Why?
|
| Severity of Illness Index | 2 | 2005 | 15841 | 0.020 |
Why?
|
| Stroke | 1 | 2011 | 9721 | 0.020 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2009 | 278 | 0.020 |
Why?
|
| Treatment Outcome | 3 | 2012 | 64681 | 0.020 |
Why?
|
| Prevalence | 1 | 2005 | 15721 | 0.020 |
Why?
|
| Kaempferols | 1 | 2007 | 21 | 0.020 |
Why?
|
| Brassica | 1 | 2007 | 39 | 0.020 |
Why?
|
| Abdominal Fat | 1 | 2009 | 221 | 0.020 |
Why?
|
| Odds Ratio | 2 | 2009 | 9652 | 0.020 |
Why?
|
| Hemodynamics | 1 | 1997 | 4165 | 0.020 |
Why?
|
| Electrocardiography | 2 | 2012 | 6387 | 0.020 |
Why?
|
| Fibrinogen | 1 | 2009 | 888 | 0.020 |
Why?
|
| Nurses | 2 | 2007 | 2477 | 0.020 |
Why?
|
| Blood Urea Nitrogen | 1 | 2006 | 186 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2010 | 1636 | 0.020 |
Why?
|
| HIV Infections | 1 | 2012 | 17348 | 0.020 |
Why?
|
| Heart Murmurs | 1 | 2006 | 92 | 0.020 |
Why?
|
| Rest | 1 | 2010 | 920 | 0.020 |
Why?
|
| California | 1 | 2009 | 1431 | 0.020 |
Why?
|
| Anticoagulants | 1 | 2000 | 4795 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2001 | 8002 | 0.010 |
Why?
|
| Drug Evaluation | 1 | 2006 | 641 | 0.010 |
Why?
|
| Arrhythmias, Cardiac | 2 | 2005 | 2247 | 0.010 |
Why?
|
| Glucuronidase | 1 | 2005 | 202 | 0.010 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2006 | 321 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2005 | 17897 | 0.010 |
Why?
|
| Hospitals, University | 1 | 2005 | 565 | 0.010 |
Why?
|
| Confidence Intervals | 1 | 2009 | 2928 | 0.010 |
Why?
|
| Anthropometry | 1 | 2008 | 1338 | 0.010 |
Why?
|
| Prognosis | 2 | 2017 | 29688 | 0.010 |
Why?
|
| Anti-Retroviral Agents | 1 | 2012 | 1784 | 0.010 |
Why?
|
| Physicians | 1 | 2001 | 4584 | 0.010 |
Why?
|
| Vitamins | 1 | 2011 | 1634 | 0.010 |
Why?
|
| Protein Precursors | 1 | 2005 | 1132 | 0.010 |
Why?
|
| Delphi Technique | 1 | 2005 | 848 | 0.010 |
Why?
|
| Drug Therapy, Combination | 2 | 2001 | 6304 | 0.010 |
Why?
|
| Japan | 1 | 2005 | 1378 | 0.010 |
Why?
|
| Pulse | 1 | 2000 | 218 | 0.010 |
Why?
|
| Comorbidity | 2 | 2005 | 10516 | 0.010 |
Why?
|
| Troponin T | 1 | 2005 | 780 | 0.010 |
Why?
|
| Aspirin | 1 | 2011 | 3129 | 0.010 |
Why?
|
| Risk Reduction Behavior | 1 | 2005 | 1111 | 0.010 |
Why?
|
| Analgesics | 1 | 2006 | 1068 | 0.010 |
Why?
|
| Physical Examination | 1 | 2005 | 1255 | 0.010 |
Why?
|
| Observer Variation | 1 | 2005 | 2610 | 0.010 |
Why?
|
| China | 1 | 2005 | 2374 | 0.010 |
Why?
|
| Creatine Kinase | 1 | 2000 | 684 | 0.010 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2004 | 1086 | 0.010 |
Why?
|
| Demography | 1 | 2003 | 1641 | 0.010 |
Why?
|
| Hypercholesterolemia | 1 | 2005 | 1141 | 0.010 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2005 | 1724 | 0.010 |
Why?
|
| Health Personnel | 1 | 2011 | 3337 | 0.010 |
Why?
|
| Glomerular Filtration Rate | 1 | 2005 | 2182 | 0.010 |
Why?
|
| Contrast Media | 1 | 2010 | 5311 | 0.010 |
Why?
|
| Fever | 1 | 2004 | 1618 | 0.010 |
Why?
|
| Case-Control Studies | 2 | 2007 | 22174 | 0.010 |
Why?
|
| Life Style | 1 | 2008 | 3907 | 0.010 |
Why?
|
| Inflammation Mediators | 1 | 2005 | 1885 | 0.010 |
Why?
|
| Coronary Artery Bypass | 1 | 2005 | 2193 | 0.010 |
Why?
|
| Preoperative Care | 1 | 2004 | 2241 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 1999 | 12159 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2000 | 2854 | 0.010 |
Why?
|
| Heart Rate | 1 | 2006 | 4197 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2011 | 10218 | 0.010 |
Why?
|
| Testosterone | 1 | 2005 | 2472 | 0.010 |
Why?
|
| Overweight | 1 | 2005 | 2418 | 0.010 |
Why?
|
| Echocardiography | 1 | 2005 | 5006 | 0.010 |
Why?
|
| Length of Stay | 1 | 2006 | 6417 | 0.010 |
Why?
|
| Boston | 1 | 2005 | 9327 | 0.010 |
Why?
|
| Alcohol Drinking | 1 | 2005 | 4027 | 0.010 |
Why?
|
| Logistic Models | 1 | 2007 | 13249 | 0.010 |
Why?
|
| Genotype | 1 | 2005 | 12985 | 0.010 |
Why?
|
| Sex Factors | 1 | 2005 | 10553 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2000 | 6345 | 0.010 |
Why?
|
| Kidney | 1 | 2005 | 7033 | 0.010 |
Why?
|
| Diabetes Mellitus | 1 | 2008 | 5842 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2005 | 7851 | 0.000 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2005 | 15920 | 0.000 |
Why?
|
| Anti-Bacterial Agents | 1 | 2004 | 7407 | 0.000 |
Why?
|